Elevance Health BDR (E1LV34)

B3
Currency in BRL
491.00
0.00(0.00%)
Delayed Data

E1LV34 Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa121,868138,643156,599171,340176,810
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.94%+13.76%+12.95%+9.41%+3.19%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa88,045102,571116,642124,330127,567
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa33,82336,07239,95747,01049,243
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+50.82%+6.65%+10.77%+17.65%+4.75%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa27.75%26.02%25.52%27.44%27.85%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa25,56327,04531,46337,12139,171
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+62.88%+5.8%+16.34%+17.98%+5.52%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa25,20226,60430,69636,23638,591
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,2609,0278,4949,88910,072
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+22.7%+9.29%-5.9%+16.42%+1.85%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa6.78%6.51%5.42%5.77%5.7%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-785-802-855-1,030-1,185
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-5.37%-2.17%-6.61%-20.47%-15.05%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-785-802-855-1,030-1,185
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,4758,2257,6398,8598,887
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa----201
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-584-28--392-692
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,2387,9957,6007,7157,904
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.23%+28.17%-4.94%+1.51%+2.45%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa5.12%5.77%4.85%4.5%4.47%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,6661,8461,7121,7241,933
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa4,5726,1495,8885,9915,971
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-96-49
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,5726,1585,8945,9875,980
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-4.89%+34.69%-4.29%+1.58%-0.12%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa3.75%4.44%3.76%3.49%3.38%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,5726,1585,8945,9875,980
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa18.2325.2624.5625.3825.68
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-3.11%+38.56%-2.77%+3.34%+1.17%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa17.9824.9524.2825.2225.68
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2.65%+38.77%-2.69%+3.87%+1.81%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa250.8243.8240235.9232.9
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa254.3246.8242.8237.4232.9
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.84.525.125.926.52
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+18.75%+18.95%+13.27%+15.63%+10.14%
EBITDA
aa.aaaa.aa